The main objective of this study is to assess the ovarian reserve of CF patients via measurement of AMH and AFC. Secondly, we aim to correlate between the ovarian reserve and demographic and clinical characteristics of these patients. Outcomes measured will be levels of AMH and AFC, as compared to standard means in the general population. There is no need for a control group in this study since the standardized means of AMH and AFC in the general population are a more accurate comparable measure, which is based on data collected from large-scale populations, and thus accounts for confounding age factor in a more complete manner than can be obtained via a control group (Almog et al., 2011, La Marca et al., 2012, Penzias et al., 2020).
Study Type
OBSERVATIONAL
Enrollment
30
Hadassah Medical Organization, Jerusalem, Israel
Jerusalem, Israel
RECRUITINGAMH levels
Levels of Anti-Mullerian hormone
Time frame: 24 hours
Antral follicular count
Antral follicular count as assessed by ultrasound
Time frame: Through study completion, an average of 1 year.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.